Literature DB >> 32453908

Endothelin signaling promotes melanoma tumorigenesis driven by constitutively active GNAQ.

Fagun Jain1, Anne Longakit1, Jenny Li-Ying Huang1, Catherine D Van Raamsdonk1.   

Abstract

The G-protein-coupled receptor, endothelin receptor B (EDNRB), is an important regulator of melanocyte survival and proliferation. It acts by stimulating downstream heterotrimeric G proteins, such as Gαq and Gα1 . Constitutively active, oncogenic versions of Gαq and Gα11 drive melanomagenesis, but the role of Ednrb in the context of these mutant G proteins has not been previously examined. In this paper, we used a knock-in mouse allele at the Rosa26 locus to force oncogenic GNAQQ209L expression in melanocytes in combination with Ednrb gene knockout. The resulting pathological analysis revealed that every aspect of melanomagenesis driven by GNAQQ209L was inhibited. We conclude that even in the presence of oncogenic Gαq , the Ednrb receptor activates normal Gαq and Gα11 proteins. This likely promotes tumorigenesis by activating phospholipase C-beta, the immediate effector of Gαq/11 . These findings suggest that it might be possible to target upstream receptors to offset the effects of hyperactive G proteins, recognized as the cause of a growing number of human disorders.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  EDNRB; GNAQ; endothelin; melanocytes; uveal melanoma

Year:  2020        PMID: 32453908     DOI: 10.1111/pcmr.12900

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  4 in total

1.  Transcriptomic analysis and ednrb expression in cochlear intermediate cells reveal developmental differences between inner ear and skin melanocytes.

Authors:  Justine M Renauld; William Davis; Tiantian Cai; Claudia Cabrera; Martin L Basch
Journal:  Pigment Cell Melanoma Res       Date:  2021-02-02       Impact factor: 4.693

2.  Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma.

Authors:  Oscar Urtatiz; Amanda Haage; Guy Tanentzapf; Catherine D Van Raamsdonk
Journal:  Elife       Date:  2021-12-23       Impact factor: 8.140

Review 3.  Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Authors:  Jérémy H Raymond; Zackie Aktary; Lionel Larue; Véronique Delmas
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

4.  Stabilization of β-catenin promotes melanocyte specification at the expense of the Schwann cell lineage.

Authors:  Sophie Colombo; Valérie Petit; Roselyne Y Wagner; Delphine Champeval; Ichiro Yajima; Franck Gesbert; Zackie Aktary; Irwin Davidson; Véronique Delmas; Lionel Larue
Journal:  Development       Date:  2022-01-24       Impact factor: 6.868

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.